Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study. Biomol Biomed [Internet]. 2021 Jun. 1 [cited 2024 May 2];21(3):339-45. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/4770